IgE-mediated fungal allergy in allergic fungal sinusitis

Laryngoscope

Volumn 119, Issue 6, 2009, Pages 1046-1052

  Pant, Harshita ^a,b,d   Schembri, Mark A ^c   Wormald, Peter J ^a,b   Macardle, Peter J ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

^d University of Pittsburgh School of Medicine   (United States)

Author keywords

Allergic fungal sinusitis; Allergy; Chronic rhinosinusitis; Mucosal inflammatory response

Indexed keywords

ANTIFUNGAL AGENT; CORTICOSTEROID; IMMUNOGLOBULIN E; IMMUNOMODULATING AGENT;

ALLERGIC FUNGAL SINUSITIS; ANTIBODY RESPONSE; CHRONIC INFLAMMATION; CHRONIC SINUSITIS; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE CLASSIFICATION; DISEASE MODEL; EOSINOPHIL; FUNGAL STRAIN; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; MUCOSA CELL; MUCOSA INFLAMMATION; NONHUMAN; NOSE MUCOSA; NOSE POLYP; NOSE SURGERY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RHINOSINUSITIS; SINUSITIS; BLOOD; CHRONIC DISEASE; EOSINOPHILIA; FUNGUS; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOLOGY; MUCOSA; PERENNIAL RHINITIS;

CHRONIC DISEASE; EOSINOPHILIA; FUNGI; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; MUCOUS MEMBRANE; RHINITIS, ALLERGIC, PERENNIAL; SINUSITIS;

EID: 66849083645     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.20170     Document Type: Review

References (79)

1. Bent JP III, Kuhn FA. Diagnosis of allergic fungal sinusitis. Otolaryngol Head Neck Surg 1994; 111:580-588.
2. Johansson SG, Hourihane JO, Bousquet J., et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001; 56:813-824.
3. Pant H., Kette FE, Smith WB, Macardle PJ, Wormald PJ. Eosinophilic mucus chronic rhinosinusitis: clinical subgroups or a homogeneous pathogenic entity? Laryngoscope 2006; 116:1241-1247.
4. Collins MM, Nair SB, Wormald PJ. Prevalence of noninvasive fungal sinusitis in South Australia. Am J Rhinol 2003; 17:127-132.
5. Ferguson BJ. Eosinophilic mucin rhinosinusitis: a distinct clinicopathological entity. Laryngoscope 2000; 110:799-813.
6. Katzenstein AL, Sale SR, Greenberger PA. Allergic Aspergillus sinusitis: a newly recognized form of sinusitis. J Allergy Clin Immunol 1983; 72:89-93.
7. Safirstein BH. Allergic bronchopulmonary aspergillosis with obstruction of the upper respiratory tract. Chest 1976; 70: 788-790.
8. Lamb D., Miller J., Johnston A. Allergic Aspergillosis of the paranasal pinuses [Abstract]. Thorax 1981; 36:710.
9. Robson JM, Hogan PG, Benn RA, Gatenby PA. Allergic fungal sinusitis presenting as a paranasal sinus tumour. Aust N Z J Med 1989; 19:351-353.
10. Anderson DM, Keith J., Novak PD. Dorland's Illustrated Medical Dictionary. Philadelphia, PA: W.B. Saunders, 1994.
11. Katzenstein AL, Sale SR, Greenberger PA. Pathologic findings in allergic aspergillus sinusitis. A newly recognized form of sinusitis. Am J Surg Pathol 1983; 7:439-443.
12. Marple BF. Allergic fungal rhinosinusitis: current theories and management strategies. Laryngoscope 2001; 111:1006-1019.
13. Ponikau JU, Sherris DA, Kern EB, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 1999; 74:877-884.
14. deShazo RD, Swain RE. Diagnostic criteria for allergic fungal sinusitis. J Allergy Clin Immunol 1995; 96:24-35.
15. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 2004; 114:155-212.
16. Manning SC, Holman M. Further evidence for allergic pathophysiology in allergic fungal sinusitis. Laryngoscope 1998; 108:1485-1496.
17. Khan DA, Cody DT II, George TJ, Gleich GJ, Leiferman KM. Allergic fungal sinusitis: an immunohistologic analysis. J Allergy Clin Immunol 2000; 106:1096-1101.
18. Feger TA, Rupp NT, Kuhn FA, Ford JL, Dolen WK. Local and systemic eosinophil activation in allergic fungal sinusitis. Ann Allergy Asthma Immunol 1997; 79:221-225.
19. Mabry RL, Marple BF, Mabry CS. Mold testing by RAST and skin test methods in patients with allergic fungal sinusitis. Otolaryngol Head Neck Surg 1999; 121:252-254.
20. Pant H., Kette FE, Smith WB, Wormald PJ, Macardle PJ. Fungal-specific humoral response in eosinophilic mucus chronic rhinosinusitis. Laryngoscope 2005; 115:601-606.
21. Mabry RL, Manning SC, Mabry CS. Immunotherapy in the treatment of allergic fungal sinusitis. Otolaryngol Head Neck Surg 1997; 116:31-35.
22. Folker RJ, Marple BF, Mabry RL, Mabry CS. Treatment of allergic fungal sinusitis: a comparison trial of postoperative immunotherapy with specific fungal antigens. Laryngoscope 1998; 108:1623-1627.
23. Collins M., Nair S., Smith W., Kette F., Gillis D., Wormald PJ. Role of local immunoglobulin E production in the pathophysiology of noninvasive fungal sinusitis. Laryngoscope 2004; 114:1242-1246.
24. *. Clin Exp Allergy 2001; 31:1896-1905.
25. Bhagat R., Shah A., Jaggi OP, Khan ZU. Concomitant allergic bronchopulmonary aspergillosis and allergic Aspergillus sinusitis with an operated aspergilloma. J Allergy Clin Immunol 1993; 91:1094-1096.
26. Dixon DM, Polak-Wyss A. The medically important dematiaceous fungi and their identification. Mycoses 1991; 34: 1-18.
27. Thakar A., Sarkar C., Dhiwakar M., Bahadur S., Dahiya S. Allergic fungal sinusitis: expanding the clinicopathologic spectrum. Otolaryngol Head Neck Surg 2004; 130:209-216.
28. Mukherji SK, Figueroa RE, Ginsberg LE, et al. Allergic fungal sinusitis: CT findings. Radiology 1998; 207:417-422.
29. Nussenbaum B., Marple BF, Schwade ND. Characteristics of bony erosion in allergic fungal rhinosinusitis. Otolaryngol Head Neck Surg 2001; 124:150-154.
30. Marple BF, Mabry RL. Comprehensive management of allergic fungal sinusitis. Am J Rhinol 1998; 12:263-268.
31. Schubert MS. Medical treatment of allergic fungal sinusitis. Ann Allergy Asthma Immunol 2000; 85:90-97; quiz 97-101.
32. Ebbens FA, Scadding GK, Badia L., et al. Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol 2006; 118:1149-1156.
33. Ponikau JU, Sherris DA, Kita H., Kern EB. Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis. J Allergy Clin Immunol 2002; 110:862-866.
34. Schubert MS, Goetz DW. Evaluation and treatment of allergic fungal sinusitis. II. Treatment and follow-up. J Allergy Clin Immunol 1998; 102:395-402.
35. Hinson KFW, Moon AJ, Plummer NS. Bronchopulmonary aspergillosis-a review and report of eight new cases. Thorax 1952; 7:317-333.
36. Greenberger PA. Allergic bronchopulmonary aspergillosis. In: Grammer LC, Greenberger PA, eds. Patterson's Allergic Disease. Philadelphia, PA: Lippincott Williams and Wilkins, 2002:529-553.
37. Kurup VP, Hari V., Guo J., et al. Aspergillus fumigatus peptides differentially express Th1 and Th2 cytokines. Peptides 1996; 17:183-190.
38. Riley DJ, Mackenzie JW, Uhlman WE, Edelman NH. Allergic bronchopulmonary aspergillosis: evidence of limited tissue invasion. Am Rev Respir Dis 1975; 111:232-236.
39. Slavin RG, Bedrossian CW, Hutcheson PS, et al. A pathologic study of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1988; 81:718-725.
40. Maurer D., Ebner C., Reininger B., et al. The high affinity IgE receptor (Fc epsilon RI) mediates IgE-dependent allergen presentation. J Immunol 1995; 154:6285-6290.
41. Coombs RRA, Gell PGH. Classification of allergic reactions responsible for clinical hypersensitivity and disease. In: Gell, PGH, Coombs RRA, eds. Clinical Aspects of Immunology. Oxford, UK: Blackwell Scientific, 1968:575-596.
42. Manning SC, Mabry RL, Schaefer SD, Close LG. Evidence of IgE-mediated hypersensitivity in allergic fungal sinusitis. Laryngoscope 1993; 103:717-721.
43. Braun H., Buzina W., Freudenschuss K., Beham A., Stammberger H. 'Eosinophilic fungal rhinosinusitis': a common disorder in Europe? Laryngoscope 2003; 113:264-269.
44. Slavin RG. Nasal polyps and sinusitis. JAMA 1997; 278: 1849-1854.
45. Horner WE, Helbling A., Salvaggio JE, Lehrer SB. Fungal allergens. Clin Microbiol Rev 1995; 8:161-179.
46. Smurthwaite L., Durham SR. Local IgE synthesis in allergic rhinitis and asthma. Curr Allergy Asthma Rep 2002; 2: 231-238.
47. Sanchez-Segura A., Brieva JA, Rodriguez C. Regulation of immunoglobulin secretion by plasma cells infiltrating nasal polyps. Laryngoscope 2000; 110:1183-1188.
48. Whiteside TL, Rabin BS, Zetterberg J., Criep L. The presence of IgE on the surface of lymphocytes in nasal polyps. J Allergy Clin Immunol 1975; 55:186-194.
49. Liu CM, Shun CT, Hsu MM. Lymphocyte subsets and antigen-specific IgE antibody in nasal polyps. Ann Allergy 1994; 72:19-24.
50. Drake-Lee AB, Barker TH. Free and cell bound IgE in nasal polyps. J Laryngol Otol 1984; 98:795-801.
51. Powe DG, Huskisson RS, Carney AS, Jenkins D., Jones NS. Evidence for an inflammatory pathophysiology in idiopathic rhinitis. Clin Exp Allergy 2001; 31:864-872.
52. Stallman PJ, Wagenaar SS, Swierenga J., van der Wal RJ, Feltkamp-Vroom TM. Cell-bound IgE on human mast cells and basophilic granulocytes in atopic and nonatopic subjects. Int Arch Allergy Appl Immunol 1977; 54: 443-450.
53. O'Donoghue DP, Kumar P. Rectal IgE cells in inflammatory bowel disease. Gut 1979; 20:149-153.
54. Marshall JS, McCurdy JD, Olynych T. Toll-like receptormediated activation of mast cells: implications in allergic disease? Int Arch Allergy Immunol 2003; 132:87-97.
55. Marshall JS, King CA, McCurdy JD. Mast cell cytokine and chemokine responses to bacterial and viral infection. Curr Pharm Des 2003; 9:11-24.
56. Robbie-Ryan M., Brown M. The role of mast cells in allergy and autoimmunity. Curr Opin Immunol 2002; 14:728-733.
57. Beil WJ, McEuen AR, Schulz M., et al. Selective alterations in mast cell subsets and eosinophil infiltration in two complementary types of intestinal inflammation: ascariasis and Crohn's disease. Pathobiology 2002; 70:303-313.
58. Tran KN, Beule AG, Singal D., Wormald PJ. Frontal ostium restenosis after the endoscopic modified Lothrop procedure. Laryngoscope 2007; 117:1457-1462.
59. Ferguson BJ. Categorization of eosinophilic chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 2004; 12: 237-242.
60. Healy DY, Leid JG, Sanderson AR, Hunsaker DH. Biofilms with fungi in chronic rhinosinusitis. Otolaryngol Head Neck Surg 2008; 138:641-647.
61. Psaltis AJ, Ha KR, Beule AG, Tan LW, Wormald PJ. Confocal scanning laser microscopy evidence of biofilms in patients with chronic rhinosinusitis. Laryngoscope 2007; 117:1302-1306.
62. Claeys S., De Belder T., Holtappels G., et al. Macrophage mannose receptor in chronic sinus disease. Allergy 2004; 59:606-612.
63. Dong Z., Yang Z., Wang C. Expression of TLR2 and TLR4 messenger RNA in the epithelial cells of the nasal airway. Am J Rhinol 2005; 19:236-239.
64. Lane AP, Truong-Tran QA, Myers A., Bickel C., Schleimer RP. Serum amyloid A., properdin, complement 3, and tolllike receptors are expressed locally in human sinonasal tissue. Am J Rhinol 2006; 20:117-123.
65. Lane AP, Truong-Tran QA, Schleimer RP. Altered expression of genes associated with innate immunity and inflammation in recalcitrant rhinosinusitis with polyps. Am J Rhinol 2006; 20:138-144.
66. Ramanathan M Jr, Lee WK, Dubin MG, Lin S., Spannhake EW, Lane AP. Sinonasal epithelial cell expression of tolllike receptor 9 is decreased in chronic rhinosinusitis with polyps. Am J Rhinol 2007; 21:110-116.
67. Viswanathan H., Brownlee IA, Pearson JP, Carrie S. MUC5B secretion is up-regulated in sinusitis compared with controls. Am J Rhinol 2006; 20:554-557.
68. Ooi EH, Wormald PJ, Carney AS, James CL, Tan LW. Human cathelicidin antimicrobial peptide is up-regulated in the eosinophilic mucus subgroup of chronic rhinosinusitis patients. Am J Rhinol 2007; 21:395-401.
69. Psaltis AJ, Wormald PJ, Ha KR, Tan LW. Reduced levels of lactoferrin in biofilm-associated chronic rhinosinusitis. Laryngoscope 2008; 118:895-901.
70. Inoue Y., Matsuwaki, Y., Shin, SH, Ponikau, JU, Kita, H. Nonpathogenic, environmental fungi induce activation and degranulation of human eosinophils. J Immunol 2005; 175:5439-5447.
71. Hussein MR, Musalam AO, Assiry MH, Eid RA, El Motawa AM, Gamel AM. Histological and ultrastructural features of gastrointestinal basidiobolomycosis. Mycol Res 2007; 111:926-930.
72. Shi HZ, Humbles A., Gerard C., Jin Z., Weller PF. Lymph node trafficking and antigen presentation by endobronchial eosinophils. J Clin Invest 2000; 105:945-953.
73. Adamko DJ, Odemuyiwa SO, Vethanayagam D., Moqbel R. The rise of the phoenix: the expanding role of the eosinophil in health and disease. Allergy 2005; 60:13-22.
74. Teixeira MM, Robinson MK, Shock A., Hellewell PG. Alpha (4) integrin-dependent eosinophil recruitment in allergic but not non-allergic inflammation. Br J Pharmacol 2001; 132:596-604.
75. Erjefalt JS, Greiff L., Andersson M., Adelroth E., Jeffery PK, Persson CG. Degranulation patterns of eosinophil granulocytes as determinants of eosinophil driven disease. Thorax 2001; 56:341-344.
76. Blom M., Tool AT, Mul FP, Knol EF, Roos D., Verhoeven AJ. Eosinophils isolated with two different methods show different characteristics of activation. J Immunol Methods 1995; 178:183-193.
77. Jiang H., Chess L. An integrated view of suppressor T cell subsets in immunoregulation. J Clin Invest 2004; 114: 1198-1208.
78. Sallusto F., Geginat J., Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 2004; 22:745-763.
79. De Rosa SC, Herzenberg LA, Roederer M. 11-color, 13-parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity. Nat Med 2001; 7:245-248.